ARTICLE | Clinical News
Parkinson’s diagnostic: Phase II data
August 11, 2008 7:00 AM UTC
In a Phase II trial comparing whole blood samples from 20 patients with mild to moderate Parkinson’s disease (PD) to 32 age-matched control subjects, Molecular Biometrics used spectroscopic analysis t...